Merit Medical Systems (MMSI) EBITDA (2010 - 2026)

Merit Medical Systems (MMSI) has 17 years of EBITDA data on file, last reported at $44.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 7.61% year-over-year to $44.2 million; the trailing twelve-month figure through Mar 2026 stood at $187.8 million (up 16.82% YoY), and the FY2025 full-year result was $184.7 million, up 18.64% from the prior year.
• EBITDA eased to $44.2 million in Q1 2026, from $54.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $54.2 million in Q4 2025 to a low of $15.2 million in Q1 2022.
• A 5-year average of $35.1 million and a median of $35.9 million in 2024 frame the typical range for EBITDA.
• Across the five-year window, EBITDA jumped 161.45% in 2022 and advanced 2.03% in 2025, its largest moves.
• Tracing MMSI's EBITDA over 5 years: stood at $30.4 million in 2022, then advanced by 10.5% to $33.6 million in 2023, then advanced by 8.78% to $36.6 million in 2024, then surged by 48.22% to $54.2 million in 2025, then slipped by 18.52% to $44.2 million in 2026.
• Business Quant data shows MMSI's EBITDA at $44.2 million in Q1 2026, $54.2 million in Q4 2025, and $42.6 million in Q3 2025.